Editing Corynebacterium diphtheriae (section)

==Vaccine==
A vaccine, DTaP, effectively prevents the disease and is mandatory in the United States for participation in public education and some professions (exceptions apply).

The invention of the toxoid vaccine, which provides protection against ''Corynebacterium diphtheriae'', caused a dramatic shift in the bacterium's rate of infection in the United States. Even though the vaccine was first made in the early 1800s, it did not become widely available until the early 1910s. According to the National Health and Nutrition Examination Survey (NHANES), "80 per cent of persons age 12 to 19 years were immune to diphtheria" due to the wide use of the vaccine in the United States.<ref>{{Cite book | vauthors = Stratton K, Ford A, Rusch E, Clayton EW |url=https://www.ncbi.nlm.nih.gov/books/NBK190028/ |title=Diphtheria Toxoid–, Tetanus Toxoid–, and Acellular Pertussis–Containing Vaccines | collaboration = Committee to Review Adverse Effects of Medicine |date=2011-08-25 |publisher=National Academies Press (US) |language=en}}</ref>